Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › GA › Lawrenceville › NPI 1306803762
Physician

Odusina, Bolaji

Odusina, Bolaji was paid $7.75M by Medicaid between Jan 2018 and Dec 2024, across 77 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.

33Billing provider infoODUSINA, BOLAJI
LAWRENCEVILLE, GA 30043
33aNPI1306803762assigned 04/28/2006
33bProvider typePediatrics Physician
28Total paid$7.75M
24GClaims300,308
24DCodes billed77
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Georgia

Rank by total paid#9 of 220
Median peer was paid$57K
This provider vs. median135×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201831,507$808K
201934,167$811K
202034,985$774K
202150,237$1.19M
202255,885$1.65M
202355,224$1.53M
2024incomplete38,303$985K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 37% 40,407 32,361 $2.84M
90460 Immunization administration through 18 years of age via any route, first or only component 8.8% 14,970 13,847 $681K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 7.3% 14,028 13,017 $564K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 5.8% 4,165 4,002 $448K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 5.4% 4,277 4,065 $417K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 5.1% 4,036 3,855 $395K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4.7% 3,696 3,430 $362K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 3.8% 3,450 3,109 $297K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 3.6% 2,852 2,671 $276K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3.1% 8,516 7,241 $239K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3.0% 6,311 5,794 $231K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2.1% 10,714 9,712 $166K
65 more codes
94010 1.3% 4,041 $103K
99050 <1% 4,225 $68K
85018 <1% 21,025 $61K
85014 <1% 21,022 $61K
96127 <1% 7,836 $56K
80061 Lipid panel <1% 2,693 $46K
99188 <1% 2,491 $42K
69210 <1% 888 $37K
86328 <1% 702 $34K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 3,256 $32K
99204 Doctor's office visit, new patient (more involved) <1% 208 $28K
81002 <1% 9,035 $25K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 138 $23K
97802 <1% 9,097 $22K
92551 <1% 7,592 $22K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 181 $19K
94060 <1% 301 $15K
99406 <1% 3,870 $15K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes <1% 8,378 $13K
99173 <1% 7,894 $11K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 673 $11K
94760 <1% 3,691 $9K
82962 <1% 2,941 $9K
0001A <1% 205 $8K
96161 <1% 2,523 $8K
96160 <1% 5,071 $8K
0002A <1% 162 $6K
94664 <1% 1,044 $6K
99401 <1% 316 $5K
99429 <1% 575 $4K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 114 $3K
90651 <1% 2,160 $3K
95004 Percutaneous tests with allergenic extracts, immediate type reaction <1% 17 $3K
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable <1% 831 $2K
36410 <1% 183 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 78 $1K
86756 <1% 100 $1K
90620 <1% 3,232 $1K
82947 <1% 196 $880.04
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel <1% 16 $632.00
91300 <1% 122 $572.38
0071A <1% 14 $560.14
71046 Radiologic examination, chest; 2 views <1% 17 $459.64
36416 <1% 14,578 $446.30
90686 <1% 3,362 $395.11
5250F <1% 1,340 $384.00
99072 <1% 1,471 $300.59
90716 <1% 1,141 $258.60
90715 <1% 893 $250.70
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 121 $192.80
90707 <1% 1,094 $145.96
90734 <1% 1,751 $128.38
90713 <1% 2,967 $127.88
80305 <1% 50 $122.70
36415 Collection of venous blood by venipuncture <1% 30 $28.80
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 98 $12.84
90633 0% 1,411 $0.00
90670 0% 2,921 $0.00
90648 0% 2,874 $0.00
90685 0% 563 $0.00
90700 0% 3,595 $0.00
G8496 All quality actions for the applicable measures in the preventive care measures group have been performed for this patient 0% 87 $0.00
90680 0% 1,806 $0.00
90744 0% 1,530 $0.00
91307 0% 49 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.